Universal Technical Institute Earnings Call Transcripts
Fiscal Year 2026
-
Q2 saw 7% revenue growth and 14% increase in new student starts, with both divisions contributing double-digit growth. Guidance for fiscal 2026 is reaffirmed, targeting 9% revenue growth and strong margin expansion, supported by robust demand, new campuses, and program launches.
-
The meeting, held virtually, covered director elections, auditor ratification, and executive compensation approval, with all proposals passing. No shareholder questions were raised, and risks related to forward-looking statements were noted.
-
Q1 2026 saw 10% revenue growth and strong student metrics, with robust demand for new campuses and programs. Fiscal 2026 guidance and long-term targets were reiterated, supported by disciplined growth investments and a favorable regulatory environment.
Fiscal Year 2025
-
Revenue grew 14% to $835.6M in 2025, exceeding guidance, with strong student and program growth. Fiscal 2026 guidance projects 9% revenue growth, $114–$119M adjusted EBITDA, and major investments in new campuses and programs. Demand for skilled trades and healthcare remains robust.
-
A leading technical and healthcare educator projects strong growth, aiming for $1.1–$1.2 billion revenue and $200+ million EBITDA by 2029, driven by campus expansion, program diversification, and robust industry partnerships. Employer demand and student outcomes remain high.
-
Q3 2025 saw revenue up 15% and net income up 114% year-over-year, with strong student growth and raised full-year guidance. Concorde's growth restrictions were lifted early, enabling accelerated expansion, while investments in new programs and campuses continue to drive momentum.
-
Celebrating 60 years, the organization is expanding with new campuses and programs, targeting sectors with strong labor demand. Financial guidance projects double-digit growth, supported by significant CapEx and robust industry partnerships.
-
Q2 2025 saw double-digit revenue and EBITDA growth, driven by strong demand in skilled trades and healthcare. Guidance for fiscal 2025 was raised across all key metrics, with continued expansion and strategic investments expected to fuel long-term growth.
-
Q1 2025 saw revenue up 15% to $201.4M, net income of $22.2M, and adjusted EBITDA up 45%. Both Concorde and UTI divisions exceeded expectations, driving raised FY25 guidance for revenue, EBITDA, and student starts. Strong demand and strategic investments support continued growth.
Fiscal Year 2024
-
Revenue grew 21% to $733M and net income reached $42M in fiscal 2024, with strong student growth and program expansion across both divisions. Fiscal 2025 guidance projects 10% revenue growth, $120–$124M in adjusted EBITDA, and continued investment in new campuses and programs.
-
A leading technical and healthcare education provider projects strong financial growth, with 2024 revenue expected at $720–$730 million and plans to reach $1–$1.2 billion by 2029. Expansion will be funded by operating cash, focusing on new programs, campuses, and entry into nursing.
-
Q3 saw 16% revenue growth, 61% higher adjusted EBITDA, and strong student metrics, with Concorde outperforming and UTI poised for a Q4 rebound. Fiscal 2024 guidance was reaffirmed, and long-term plans target 10% revenue CAGR and 20% EBITDA margin by 2029.